Cargando…

Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation

Detalles Bibliográficos
Autores principales:	Lin, Kimberly C., Moroishi, Toshiro, Meng, Zhipeng, Jeong, Han-Sol, Plouffe, Steven W., Sekido, Yoshitaka, Han, Jiahuai, Park, Hyun Woo, Guan, Kun-Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541894/ https://www.ncbi.nlm.nih.gov/pubmed/28752853 http://dx.doi.org/10.1038/ncb3581

Ejemplares similares

Mechanisms of Hippo pathway regulation
por: Meng, Zhipeng, et al.
Publicado: (2016)

A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
por: Moroishi, Toshiro, et al.
Publicado: (2015)

Hippo Pathway in Mammalian Adaptive Immune System
por: Yamauchi, Takayoshi, et al.
Publicado: (2019)

Autopalmitoylation of TEAD Proteins Regulates Transcriptional Output of Hippo Pathway
por: Chan, PuiYee, et al.
Publicado: (2016)

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
por: Meng, Zhipeng, et al.
Publicado: (2015)

RAP2 Mediates Mechano-responses of Hippo Pathway
por: Meng, Zhipeng, et al.
Publicado: (2018)

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
por: Holden, Jeffrey K., et al.
Publicado: (2018)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling
por: Fan, Mengyang, et al.
Publicado: (2022)

Regulation of TEAD Transcription Factors in Cancer Biology
por: Huh, Hyunbin D., et al.
Publicado: (2019)

Critical roles of phosphoinositides and NF2 in Hippo pathway regulation
por: Hong, Audrey W., et al.
Publicado: (2020)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming
por: Singh, Vivek P., et al.
Publicado: (2021)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
por: Qi, Yangfan, et al.
Publicado: (2016)

Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
por: Wu, Yujian, et al.
Publicado: (2021)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
por: Al-Mathkour, Marwah M., et al.
Publicado: (2022)

RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling
por: Choi, Sunkyung, et al.
Publicado: (2022)

VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017)

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
por: Kang, Wei, et al.
Publicado: (2018)

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer
por: González-Alonso, Paula, et al.
Publicado: (2020)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

Independent variant analysis of TEAD1 and OCEL1 in 38 Aicardi syndrome patients
por: Wong, Bibiana K. Y., et al.
Publicado: (2017)

Regulation of Hippo signalling by p38 signalling
por: Huang, Dashun, et al.
Publicado: (2016)

IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD
por: Unterer, Bea, et al.
Publicado: (2018)

Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells
por: Van Sciver, Nicholas, et al.
Publicado: (2021)

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
por: Sato, Tatsuhiro, et al.
Publicado: (2023)

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
por: Martin, Daniel, et al.
Publicado: (2018)

Glucocorticoids synergize with IL-1β to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells
por: Sakai, Akihiro, et al.
Publicado: (2004)

Co‐occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence
por: Yu, Le, et al.
Publicado: (2021)

CADM1 associates with Hippo pathway core kinases; membranous co–expression of CADM1 and LATS2 in lung tumors predicts good prognosis
por: Ito, Takeshi, et al.
Publicado: (2019)

Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations
por: Troilo, Albino, et al.
Publicado: (2016)

VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway
por: Xu, Kaicheng, et al.
Publicado: (2020)

Leveraging Hot Spots of TEAD–Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling
por: Zhao, Bin, et al.
Publicado: (2023)

Stress-specific p38 MAPK activation is sufficient to drive EGFR endocytosis but not its nuclear translocation
por: Tomas, Alejandra, et al.
Publicado: (2017)

Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)

The Hippo pathway mediates Semaphorin signaling
por: Meng, Zhipeng, et al.
Publicado: (2022)

Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade
por: Fujii, Makiko, et al.
Publicado: (2012)

Cell type-dependent function of LATS1/2 in cancer cell growth
por: Pan, Wei-Wei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_of5971r3n26o0i2cogun4e6plq